COVID-19. U07.2COVID-19, virus not identified, COVID-19
Conditions
Interventions
Intervention 1: Intervention group:The group uses the following herbal medicine in addition to the current medicine for Covid-19: Drug Name: Pinene-Hydronoplactone-Ribonucleoic-Abbreviation: PHR160 -
Sponsors
Bagheiat-allah University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Male or female patients 18-65 years with COVID-19 confirmed by PCR (with mild involvement) - Ground glass view on CT scan - Arterial oxygen saturation less than 93% - Breathing more than 24 times per minute - At the Beginning onset of the disease - Negative pregnancy test in women - Completion of informed consent form by patient or supervisor
Exclusion criteria
Exclusion criteria: Oral ulcer or malignancy - history of pulmonary malignancy - history of asthma or COPD
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Measurement of cough severity. Timepoint: Day 1 before and at the end of treatment. Method of measurement: Standard cough questionnaire.;Severity of shortness of breath. Timepoint: Day 1 before and at the end of treatment. Method of measurement: Shortness Of Breath With Daily Activity (SOBDA) Questionnaire.;Lung radiologic changes. Timepoint: At beginning and end of the study. Method of measurement: Chest CT scan. | — |
Secondary
| Measure | Time frame |
|---|---|
| CBC Test. Timepoint: At beginning and end of the study. Method of measurement: Intravenous blood sampling and standard blood cell counter device. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAhmad Reza Sharifi Olounabadi
Bagheiat-allah University of Medical Sciences
Outcome results
None listed